<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2019-02-18 22:19:01 +0000"/><meta name="latitude" content="37.76903888888889"/><meta name="longitude" content="-122.3919444444444"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2019-02-19 22:39:02 +0000"/><title>February 13, 2019</title></head><body><div>DJA2 Delta CT expression day 2:</div><div>- cultures were pelleted by centrifugation at 4000RPM for 15 min and pellets were stored at -80C</div><div><br/></div><div>EB3 ELISA day 2:</div><div>- GOAL: test a gradient of EB3 and WT tau for interaction by ELISA; upon determination of optimal conditions, this will be repeated with a closer dose range and with V337M tau</div><div>- performed by Kelly Montgomery: BCA of freshly dialyzed WT tau, final concentration 234.8uM</div><div>- prepared 800uL of 50uM tau by combining 170.36uL of tau with 629.64uL binding buffer and performed 5 2-fold dilutions by combining 400uL tau with 400uL binding buffer (concentrations prepared: 50uM, 25uM, 12.5uM, 6.25uM, 3.125uM, 1.5625uM)</div><div>- 30uL of tau (at each of the 6 respective concentrations described above) was added to each well (either wells coated with EB3 or buffer alone); as a control, 30uL of binding buffer was also added to duplicate wells</div><div>- after addition of tau to plates, ELISA was performed as described in Meredith’s protocol (see attached), except for noted changes to protocol</div><div>- changes to protocol: primary antibody was used at 1:10000 dilution (?)</div><div>- upon addition of TMB substrate, plates were allowed to incubate ~15min in a drawer at RT until blue color was achieved (see attached)</div><div>- upon addition of 1M HCl, wells turned yellow, with darkest blue wells turning darkest yellow (see attached)</div><div>- RESULTS: since a full curve wasn’t established, we will need to increase the dose range of tau to lower concentrations; it seems that all tested EB3 coating concentrations were similar, so a single concentration within that range will be used for future experiments</div><div/><div><a href="February%2013,%202019.html.resources/ELISA%20-%20Hsc70%20affinity%20fo%20tau%20%C2%B7%20Benchling.pdf">ELISA - Hsc70 affinity fo tau · Benchling.pdf</a><a href="February%2013,%202019.html.resources/021319%20EB3%20tau%20ELISA.txt">021319 EB3 tau ELISA.txt</a><br/></div><div><a href="February%2013,%202019.html.resources/021319%20EB3%20tau%20ELISA.pdf">021319 EB3 tau ELISA.pdf</a><br/></div><div><br/></div><div><img src="February%2013,%202019.html.resources/IMG_2121.JPG" /><br/></div><div><br/></div></body></html>
